Burcon NutraScience Corp.
- WKN: 157793
- ISIN: CA1208311029
- Land: Kanada
Nachricht vom 27.06.2019 | 12:00
Burcon NutraScience Corp.: BURCON ANNOUNCES COMPLETION OF OVER-SUBSCRIBED RIGHTS OFFERING
DGAP-News: Burcon NutraScience Corp. / Key word(s): Miscellaneous
BURCON ANNOUNCES COMPLETION OF OVER-SUBSCRIBED RIGHTS OFFERING
Vancouver, British Columbia, June 26, 2019 - Burcon NutraScience Corporation (TSX:BU) ("Burcon" or the "Company"), a leader in developing functionally and nutritionally valuable plant proteins, is pleased to announce the completion of its rights offering (the "Rights Offering"), which expired at 5:00pm (EST) on June 25, 2019. The Rights Offering was over-subscribed and will result in the issuance of 44,083,203 Common shares of Burcon ("Common Shares") at a price of $0.35 per share for gross proceeds of approximately $15,429,121.
Burcon is working with its transfer agent to calculate the amounts exercised under the basic subscription privilege and the additional subscription privilege in connection with the Rights Offering and will provide further details, including information required by National Instrument 45-106 - Prospectus Exemptions, once available.
About Burcon NutraScience Corporation
The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward- looking statements or forward-looking information can be identified by words such as "anticipate," "intend," "plan," "goal," "project," "estimate," "expect," "believe", "future," "likely," "may," "should," "could", "will" and similar references to future periods. All statements other than statements of historical fact included in this release are forward-looking statements, including, without limitation, statements regarding the future issuance of Common Shares and other expectations, intentions and plans contained in this press release. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the actual results of business negotiations, marketing activities, adverse general economic, market or business conditions, regulatory changes and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form dated June 18, 2018 filed with the Canadian securities administrators on www.sedar.com. Any forward-looking statement or information only speaks as of the date on which it was made and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and accordingly, investors should not rely on such statements.
CLARISOY is a trademark of Archer Daniels Midland Company.
Burcon NutraScience Corporation Announces Clos ...
Burcon NutraScience Corp.: Burcon Commences Tr ...
Burcon NutraScience Corp.: Burcon NutraScience ...
Burcon NutraScience Corp.: Burcon, Merit and N ...
Burcon NutraScience Corp.: Merit Functional Fo ...
HELMA Eigenheimbau: Klarer Kauf
Die HELMA Eigenheimbau hat mit dem Zugang weiterer Ferienimmobilienprojekte das potenzielle Umsatzvolumen um 150 Mio. € gesteigert. Ohnehin verfügt die Gesellschaft über einen umfangreichen Grundstücksbestand für das Bauträgergeschäft, womit in den kommenden Geschäftsjahren Umsätze in Höhe von über 1,4 Mrd. € realisiert werden könnten. Damit dürften unsere Schätzungen, in denen wir ein nachhaltiges Überschreiten der Umsatzmarke von 300 Mio. € annehmen, gut unterfüttert sein. Bei einem Kursziel von 65,00 € ist die HELMA-Aktie ein klarer Kauf.
Der AKTIONÄR News
21. Februar 19:03 Goldpreis nicht zu stoppen – Barrick Gold mit neuem 52-Wochen-Hoch
21. Februar 18:05 BASF-Rivale Covestro: Ans DAX-Ende durchgereicht, aber…
21. Februar 15:48 Börsenpunk: Börsenpunk: Daimler-Blues hält an / Bilibili - alles ...
21. Februar 14:44 1&1 Drillisch springt nach oben – ist das die Wende?
News im Fokus
Fresenius Medical Care veröffentlicht Form 20-F für das Geschäftsjahr 2019
21. Februar 2020, 11:54
Original-Research: Media and Games Invest plc (von First Berlin Equity Research GmbH): BUY
21. Februar 2020